Association of Combined Tobacco Smoking and Oral Contraceptive Use With Cervical Intraepithelial Neoplasia 2 or 3 in Korean Women.

Hea Young Oh, Mi Kyung Kim, Sang-Soo Seo, Jae-Kwan Lee
Author Information
  1. Hea Young Oh: Division of Cancer Epidemiology and Prevention, National Cancer Center.

Abstract

BACKGROUND: Cigarette smoking and oral contraceptive (OC) use have been associated with cervical neoplasia, and the combination of smoking and OC use could influence cervical carcinogenesis. We aimed to assess the joint effect of smoking and OC use on the risk of cervical intraepithelial neoplasia (CIN).
METHODS: From a cohort of human papillomavirus-positive subjects recruited from 6 hospitals in Korea from March 2006 to November 2012, a total of 678 subjects (411 control, 133 CIN 1, and 134 CIN 2 or 3 cases) were selected for this study (mean age, 43 years). The risk of CIN associated with smoking and OC use on additive and multiplicative scales was estimated via multinomial logistic regression after adjustment for potential confounding factors. The relative excess risk due to interaction (RERI) and the synergy index (S) were used to evaluate the additive interaction.
RESULTS: OC users (odds ratio [OR] 1.98; 95% confidence interval [CI], 1.07-3.69) and long-term OC use (≥20 months; OR 2.71; 95% CI, 1.11-6.59) had a higher risk of CIN 2/3, but had no association with CIN 1, compared to non-OC users. Smokers and heavy smoking (≥8 cigarettes/day) were not associated with any CIN grade. Combined smoking and OC use (OR 4.91; 95% CI, 1.68-14.4; RERI/S, 3.77/27.4; P for multiplicative interaction = 0.003) and combined heavy smoking and long-term OC use (OR 11.5; 95% CI, 1.88-70.4; RERI/S, 9.93/18.8; P for multiplicative interaction = 0.009) had a higher risk of CIN 2/3 but had no association with CIN 1 compared to combined non-smoking and non-OC use.
CONCLUSIONS: OC use and smoking acted synergistically to increase the risk of CIN 2 or 3 in Korean women.

References

  1. Anticancer Res. 2012 Aug;32(8):3045-54 [PMID: 22843872]
  2. J Virol. 2008 Jan;82(2):1053-8 [PMID: 17989183]
  3. Asian Pac J Cancer Prev. 2012;13(11):5489-95 [PMID: 23317205]
  4. Yonsei Med J. 2002 Dec;43(6):712-6 [PMID: 12497653]
  5. Am J Obstet Gynecol. 2007 Oct;197(4):340-5 [PMID: 17904956]
  6. Gynecol Oncol. 2007 Apr;105(1):181-8 [PMID: 17204311]
  7. BMJ Open. 2013 Nov 27;3(11):e003695 [PMID: 24285630]
  8. Anticancer Res. 2000 Sep-Oct;20(5C):3637-40 [PMID: 11268431]
  9. Gynecol Obstet Invest. 1996;41(4):253-9 [PMID: 8793496]
  10. Int J Gynaecol Obstet. 2008 Feb;100(2):175-8 [PMID: 18001738]
  11. Int J Cancer. 2008 Oct 15;123(8):1883-91 [PMID: 18688864]
  12. Br J Cancer. 2004 May 4;90(9):1787-91 [PMID: 15150591]
  13. PLoS One. 2013;8(8):e72142 [PMID: 23977233]
  14. Lancet. 2007 Nov 10;370(9599):1609-21 [PMID: 17993361]
  15. Eur J Cancer Prev. 2014 Mar;23(2):110-2 [PMID: 24469243]
  16. Anticancer Res. 2006 Nov-Dec;26(6C):4729-40 [PMID: 17214333]
  17. Taehan Kanho Hakhoe Chi. 2003 Jun;33(4):457-63 [PMID: 15314420]
  18. Gynecol Endocrinol. 2011 Aug;27(8):597-604 [PMID: 21438669]
  19. J Natl Cancer Inst. 2002 Sep 18;94(18):1406-14 [PMID: 12237286]
  20. Nat Med. 2007 Mar;13(3):367-71 [PMID: 17334373]
  21. Eur J Gynaecol Oncol. 2012;33(1):5-14 [PMID: 22439398]
  22. JAMA. 2002 Apr 24;287(16):2114-9 [PMID: 11966386]
  23. Nat Rev Immunol. 2009 May;9(5):377-84 [PMID: 19330016]
  24. Clin Obstet Gynecol. 2014 Jun;57(2):256-78 [PMID: 24686336]
  25. Int J Gynecol Cancer. 2012 Nov;22(9):1570-6 [PMID: 23051954]
  26. Carcinogenesis. 1998 Mar;19(3):433-6 [PMID: 9525277]
  27. Gynecol Obstet Invest. 1995;39(1):34-8 [PMID: 7890250]
  28. Am J Obstet Gynecol. 2009 May;200(5):489.e1-8 [PMID: 19375566]
  29. Gynecol Oncol. 2013 Feb;128(2):265-70 [PMID: 23146688]
  30. Int J Cancer. 2006 Mar 15;118(6):1481-95 [PMID: 16206285]
  31. Int J Gynecol Cancer. 2010 Jan;20(1):116-9 [PMID: 20130511]
  32. Gynecol Oncol. 2004 Apr;93(1):116-20 [PMID: 15047223]
  33. Int J Cancer. 2007 Feb 15;120(4):885-91 [PMID: 17131323]
  34. Gynecol Obstet Invest. 2011;71(2):93-103 [PMID: 21150159]
  35. Am J Obstet Gynecol. 2003 Jun;188(6):1406-12 [PMID: 12824970]
  36. J Int Med Res. 2012;40(2):486-96 [PMID: 22613409]
  37. Carcinogenesis. 1994 May;15(5):1097-100 [PMID: 8200076]
  38. Cancer Causes Control. 2010 Jan;21(1):51-9 [PMID: 19777358]
  39. Eur J Epidemiol. 2005;20(7):575-9 [PMID: 16119429]
  40. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):103-10 [PMID: 12657108]

MeSH Term

Adolescent
Adult
Aged
Case-Control Studies
Cohort Studies
Contraceptives, Oral
Female
Humans
Middle Aged
Republic of Korea
Risk Assessment
Smoking
Uterine Cervical Neoplasms
Young Adult
Uterine Cervical Dysplasia

Chemicals

Contraceptives, Oral